References and Notes
1a
Handbook of Organopalladium Chemistry for
Organic Synthesis
Vol. 1 and 2:
Negishi E.
de Meijere A.
John
Wiley & Sons;
Hoboken:
2002.
1b
Metal-Catalyzed Cross-Coupling
Reactions
2nd ed., Vol. 1 and 2:
de Meijere A.
Diederich F.
Wiley-VCH;
Weinheim:
2004.
2a
Guram AS.
Buchwald SL.
J. Am. Chem. Soc.
1994,
116:
7901
2b
Paul F.
Patt J.
Hartwig JF.
J.
Am. Chem. Soc.
1994,
116:
5969
3a
Guram AS.
Rennels RA.
Buchwald SL.
Angew. Chem.,
Int. Ed. Engl.
1995,
34:
1348
3b
Wolfe JP.
Rennels RA.
Buchwald SL.
Tetrahedron
1996,
52:
7525
3c
Wolfe JP.
Wagaw S.
Marcoux J.-F.
Buchwald SL.
Acc.
Chem. Res.
1998,
31:
805
3d
Wolfe JP.
Tomori H.
Sadighi JP.
Yin J.
Buchwald SL.
J. Org. Chem.
2000,
65:
1158
3e
Alcazar-Roman LM.
Hartwig JF.
Rheingold AL.
Liable-Sands LM.
Guzei IA.
J. Am. Chem. Soc.
2000,
122:
4618
3f
Wolfe JP.
Buchwald SL.
J.
Org. Chem.
2000,
65:
1144
4
Riou JF.
Fosse P.
Chi Hung N.
Larsen AK.
Bissery MC.
Grondard L.
Saucier JM.
Bisagni E.
Lavelle F.
Cancer Res.
1993,
53:
5987
5
Peltason L.
Bajorath J.
J. Med. Chem.
2007,
50:
5571
6
Chakraborti AK.
Gopalakrishnan B.
Sobhia ME.
Malde A.
Bioorg. Med. Chem. Lett.
2003,
13:
2473
7a
Wolfe JP.
Buchwald SL.
Tetrahedron Lett.
1997,
38:
6359
7b
Marcoux J.-F.
Wagaw S.
Buchwald SL.
J.
Org. Chem.
1997,
62:
1568
7c
Nishiyama M.
Yamamoto T.
Koie Y.
Tetrahedron
Lett.
1998,
39:
617
7d
Jaime-Figueroa S.
Liu Y.
Muchowski JM.
Putman DG.
Tetrahedron
Lett.
1998,
39:
1313
7e
Marion N.
Ecarnot EC.
Navarro O.
Amoroso D.
Bell A.
Nolan SP.
J. Org. Chem.
2006,
71:
3816
8a
Wagaw S.
Buchwald SL.
J.
Org. Chem.
1996,
61:
7240
8b
Yin J.
Zhao Matthew M.
Huffman MA.
McNamara JM.
Org.
Lett.
2002,
4:
3481
8c
Suzuki T.
Igari S.-i.
Hirasawa A.
Hata M.
Ishiguro M.
Fujieda H.
Itoh Y.
Hirano T.
Nakagawa H.
Ogura M.
Makishima M.
Tsujimoto G.
Miyata N.
J. Med. Chem.
2008,
51:
7640
9
Desmarets C.
Schneider R.
Fort Y.
Tetrahedron
Lett.
2001,
42:
247
10
Jonckers THM.
Maes BUW.
Lemiere GLF.
Dommisse R.
Tetrahedron
2001,
57:
7027
11a
Mack AG.
Suschitzky H.
Wakefield BJ.
J. Chem. Soc.,
Perkin Trans. 1
1980,
1682
11b
Zhang Q.
Liu Y.
Gao F.
Ding Q.
Cho C.
Hur W.
Jin Y.
Uno T.
Joazeiro CAP.
Gray N.
J.
Am. Chem. Soc.
2006,
128:
2182
11c
Grasa GA.
Viciu MS.
Huang J.
Nolan SP.
J.
Org. Chem.
2001,
66:
7729
11d
Shen Q.
Hartwig JF.
J. Am.
Chem. Soc.
2007,
129:
7734
12a
Norman MH.
Zhu J.
Fotsch C.
Bo Y.
Chen N.
Chakrabarti P.
Doherty EM.
Gavva NR.
Nishimura N.
Nixey T.
Ognyanov VI.
Rzasa RM.
Stec M.
Surapaneni S.
Tamir R.
Viswanadhan VN.
Treanor
JJS.
J. Med. Chem.
2007,
50:
3497
12b
Ji J.
Li T.
Bunnelle WH.
Org.
Lett.
2003,
5:
4611
13
Eicher T.
Hauptmann S. In The
Chemistry of Heterocycles
Wiley-VCH;
Weinheim:
2003.
p.269ff
14a
Estel L.
Marsais F.
Queguiner G.
J. Org. Chem.
1988,
53:
2740
14b
Rocca P.
Chochennec C.
Marsais F.
Thomas-dit-Dumont L.
Mallet M.
Godard A.
Queguiner G.
J.
Org. Chem.
1993,
58:
7832
14c
Stanetty P.
Hattinger G.
Schnürch M.
Mihovilovic MD.
J. Org. Chem.
2005,
70:
5215
15a
Stanetty P.
Schnürch M.
Mihovilovic MD.
Synlett
2003,
1862
15b
Stanetty P.
Röhrling J.
Schnürch M.
Mihovilovic MD.
Tetrahedron
2006,
62:
2380
16a
Pasumansky L.
Hernandez AR.
Gamsey S.
Goralski CT.
Singaram B.
Tetrahedron Lett.
2004,
45:
6417
16b
Menichincheri M.
Bassini DF.
Gude M.
Angiolini M.
Tetrahedron
Lett.
2003,
44:
519
16c
Perron-Sierra F.
Dizier SD.
Bertrand M.
Genton A.
Tucker GC.
Casara P.
Bioorg.
Med. Chem. Lett.
2002,
12:
3291
17
General Procedure:
2-Fluoro-4-iodopyridine (4; 1 equiv), aryl/alkyl
amine (1.2 equiv), K2CO3 (3.5 equiv), Pd(OAc)2 (2
mol%), and BINAP (2 mol%) were charged into a microwave
vial and anhydrous toluene (2 mL) was added. The vial was then sealed,
evacuated and flushed with argon. Then the reaction mixture was
irradiated at 180 ˚C in a CEM Explorer™ microwave
unit for 30 min with stirring. After cooling to r.t., the solid
material was removed by filtration and washed with CH2Cl2 (10 mL).
The solvent was evaporated and the resulting crude product was purified
by flash column chromatography.
2-Fluoro-
N
-phenylpyridin-4-amine
(5a): Yellow solid; mp 148-150 ˚C;
GC-MS: m/z (%) = 188
(100) [M]+, 187 (65), 167
(20); ¹H NMR (CDCl3, 200 MHz): δ = 6.45
(d, J = 1.7 Hz,
1 H), 6.67-6.78 (m, 2 H), 7.23 (d, J = 6.8 Hz, 3 H),
7.44 (t, J = 7.1 Hz,
2 H), 7.86 (d, J = 7.8 Hz,
1 H). ¹³C NMR (CDCl3,
50 MHz): δ = 92.5 (q, J
C-F = 44.1 Hz),
108.2 (q, J
C-F = 3.1 Hz),
122.4 (d), 129.7 (d), 138.9 (s), 147.8 (d), 138.9 (s), 147.8 (q, J
C-F = 16.6 Hz),
154.5 (d, J
C-F = 3.1 Hz), 165.5
(d, J
C-F = 221.5 Hz).
2-Fluoro-
N
-(4-methoxyphenyl)pyridin-4-amine (5b): Yellow
crystals; mp 150 ˚C; GC-MS: m/z (%) = 218 (79)[M]+,
203 (100), 155 (13); ¹H NMR (CDCl3,
200 MHz): δ = 3.83 (s, 3 H),
6.20 (d, J = 1.7 Hz,
1 H), 6.31 (s, 1 H), 6.51 (td, J
1 = 5.9 Hz, J
2 = 1.9 Hz,
1 H), 6.95 (d, J = 8.9 Hz,
2 H), 7.14 (d, J = 8.8 Hz,
2 H), 7.81 (d, J = 8.8 Hz,
1 H). ¹³C NMR (CDCl3,
50 MHz): δ = 55.5 (t), 91.6 (q, J
C-F = 42.4 Hz), 107.5
(q, J
C-F = 2.8 Hz),
114.9 (d), 125.8 (d), 131.4 (s), 147.4 (q, J
C-F = 18.7 Hz),
156.5 (d, J
C-F = 11.6 Hz),
157.6 (s), 165.5 (d, J
C-F = 232.7 Hz).
2-Fluoro-
N
-(2-methoxyphenyl)pyridin-4-amine (5c): Brown
oil; GC-MS: m/z (%) = 218 (100)[M]+,
203 (83), 175 (33); ¹H NMR (CDCl3,
200 MHz): δ = 3.85 (s, 3 H),
6.45 (d, J = 1.9 Hz,
1 H), 6.56 (s, 1 H), 6.70 (d, J = 5.8 Hz,
1 H), 6.96 (t, J = 6.9 Hz,
1 H), 7.04-7.17 (m, 1 H), 7.35 (d, J = 7.4 Hz,
1 H), 7.87 (d, J = 5.8 Hz,
1 H). ¹³C NMR (CDCl3,
50 MHz): δ = 55.6 (t), 92.8 (q, J
C-F = 42.4),
108.7 (q, J
C-F = 2.5 Hz),
111.2 (d), 120.7 (d), 120.8 (d), 124.4 (d), 128.5 (s), 147.6 (q, J
C-F = 18.4 Hz),
150.7 (s), 154.6 (d,
J
C-F = 10.2 Hz),
165.5 (d, J
C-F = 232.1 Hz).
N
-(4-Chlorophenyl)-2-fluoropyridin-4-amine
(5d): Colorless solid; mp 175-178 ˚C;
GC-MS: m/z (%) = 222 (100)[M]+,
224 (47), 186 (31); ¹H NMR (CDCl3,
200 MHz): δ = 6.31 (s, 1 H),
6.35 (d, J = 1.9 Hz,
1 H), 6.63 (d, J = 5.8 Hz,
1 H), 7.14 (d, J = 8.8 Hz,
2 H), 7.35 (d, J = 8.6 Hz,
2 H), 7.9 (d, J = 5.8 Hz,
1 H). ¹³C NMR (CDCl3, 50 MHz): δ = 92.9
(q, J
C-F = 42.7 Hz),
108.2 (q, J
C-F = 3.5 Hz),
123.8 (d), 129.9 (d), 130.3 (s), 137.5 (s), 148.1 (q, J
C-F = 17.6 Hz),
154.8 (d, J
C-F = 14.7 Hz),
165.5 (d,
J
C-F = 235.2 Hz).
Ethyl 4-(2-fluoropyridin-4-ylamino)benzoate
(5e): Light-yellow solid; mp 170 ˚C; GC-MS: m/z (%) = 260
(67)[M]+, 232 (25), 215 (100); ¹H
NMR (CDCl3, 200 MHz): δ = 1.40 (t, J = 7.1 Hz,
3 H), 4.39 (q, J = 7.2 Hz,
2 H), 6.56 (d, J = 1.7 Hz,
1 H), 6.72 (s, 1 H), 6.79 (d, J = 5.6 Hz,
1 H), 7.19-7.26 (m, 2 H), 7.97 (d, J = 5.8 Hz,
1 H), 8.06 (d, J = 8.8 Hz,
1 H). ¹³C NMR (CDCl3,
50 MHz): δ = 14.4 (q), 60.9 (t), 94.2
(q, J
C-F = 41.3 Hz),
109.2 (q, J
C-F = 3.5 Hz), 119.5
(d), 125.7 (s), 131.4 (d), 143.5 (s), 148.2 (q,
J
C-F = 19.2 Hz),
153.4 (d, J
C-F = 11.3 Hz),
165.9 (d,
J
C-F = 234.3 Hz).
4-(2-Fluoropyridin-4-ylamino)benzonitrile(5f): Yellow solid;
mp 195-197 ˚C; GC-MS: m/z (%) = 213 (100)[M]+, 212
(45), 192 (16); ¹H NMR (CD3OD, 200 MHz): δ = 6.68 (d, J = 1.7 Hz,
1 H), 6.98 (d, J = 5.8 Hz,
1 H), 7.35 (d, J = 8.6 Hz,
2 H), 7.70 (d, J = 8.6 Hz,
2 H), 7.92 (d, J = 6.6 Hz,
1 H). ¹³C NMR (CD3OD,
50 MHz): δ = 97.6 (q, J
C-F = 39.9 Hz),
108.8 (d), 113.2 (q, J
C-F = 3.2 Hz),
122.16 (s), 123.1 (d), 137.4 (d), 148.67 (d), 151.1 (q, J
C-F = 15.8 Hz),
158.0 (d, J
C-F = 11.6 Hz),
169.2 (d, J
C-F = 234.1 Hz).
2-Fluoro-
N
-(4-phenoxyphenyl)pyridin-4-amine (5g): Brown
crystals; mp 149 ˚C; GC-MS: m/z (%) = 280 (100)[M]+,
203 (63), 77 (41); ¹H NMR (CDCl3,
200 MHz): δ = 6.51 (d, J = 1.9 Hz,
1 H), 6.61 (s, 1 H), 6.81 (d, J = 5.8 Hz,
1 H), 7.23 (d, J = 2.1 Hz,
2 H), 7.37 (m, 3 H), 7.48 (s, 1 H), 7.57
(t, J = 7.9 Hz,
3 H), 8.80 (d, J = 5.8 Hz, 1 H). ¹³C
NMR (CDCl3, 50 MHz): δ = 92.0
(q, J
C-F = 39.5 Hz),
107.8 (q, J
C-F = 3.2 Hz),
118.9 (d), 119.9 (d), 123.5 (d), 125.0 (d), 129.9 (d), 133.9 (s),
147.9 (q, J
C-F = 22.9 Hz),
154.8 (s), 155.8 (d, J
C-F = 11.9 Hz),
157.0 (s), 165.6 (d, J
C-F = 233.0 Hz).
2-Fluoro-
N
-(4-morpholinophenyl)pyridin-4-amine (5h): Colorless
crystals; mp 154 ˚C; GC-MS: m/z (%) = 273 (100)[M]+,
215 (80), 214 (21); ¹H NMR (CDCl3,
200 MHz): δ = 3.16 (s, 4 H),
3.88 (t, J = 4.8 Hz,
4 H), 6.21 (s, 1 H), 6.28 (s, 1 H), 6.50
(d, J = 5.6 Hz,
1 H), 6.93 (d, J = 6.9 Hz,
2 H), 7.10 (d, J = 8.6 Hz,
2 H), 7.81 (d, J = 6.3 Hz,
1 H). ¹³C NMR (CDCl3,
50 MHz): δ = 49.4 (t), 66.8 (t), 91.7
(q, J
C-F = 43.7 Hz),
107.6 (q, J
C-F = 3.2 Hz),
116.6 (d), 125.2 (d), 130.9 (s), 147.4 (q, J
C-F = 17.3 Hz),
149.1 (s), 156.4 (d,
J
C-F = 13.7 Hz),
165.5 (d, J
C-F = 233.0 Hz).
N
-Benzyl-2-fluoropyridin-4-amine
(5i): Yellow oil; GC-MS: m/z (%) = 202 (42)[M]+,
91 (100), 65 (11); ¹H NMR (CDCl3,
200 MHz): δ = 4.36 (d, J = 4.4 Hz,
2 H), 5.03 (s, 1 H), 6.00 (d, J = 1.8 Hz,
1 H), 6.32-6.40 (m, 1 H), 7.27-7.38
(m, 5 H), 7.75 (d, J = 5.4 Hz,
1 H). ¹³C NMR (CDCl3, 50 MHz): δ = 45.2
(t), 88.5 (q, J
C-F = 51.2 Hz),
104.9 (q,
J
C-F = 2.4 Hz),
125.8 (d), 126.1 (d), 135.5 (s), 145.1 (q,
J
C-F = 19.1 Hz),
155.5 (d, J
C-F = 12.3 Hz),
161.3 (d), 165.8 (d, J
C-F = 232.2 Hz).
2-Fluoro-
N
-(4-methoxybenzyl)pyridin-4-amine (5j): Yellow
solid; mp 123-124 ˚C; GC-MS: m/z (%) = 121 (100),
122 (9), 232 (7)[M]+; ¹H
NMR (CDCl3, 200 MHz):
δ = 3.73
(s, 3 H), 4.20 (d, J = 5.3 Hz,
2 H), 4.75 (s, 1 H), 5.92 (d, J = 1.8 Hz,
1 H), 6.27 (td, J
1 = 5.9 Hz, J
2 = 1.8 Hz,
1 H), 6.82 (d, J = 8.8 Hz,
2 H), 7.16 (d, J = 8.8 Hz,
2 H), 7.69 (d, J = 5.5 Hz,
1 H). ¹³C NMR (CDCl3,
50 MHz): δ = 46.7 (t), 55.3 (q), 90.4
(q, J
C-F = 42.7 Hz),
106.9 (q, J
C-F = 2.5 Hz), 114.3
(d), 128.8 (d), 129.2 (s), 147.2 (q, J
C-F = 18.7 Hz), 157.3
(d, J
C-F = 12.0 Hz),
159.2 (s), 165.5 (d, J
C-F = 232.1 Hz).
2-Fluoro-4-(piperidin-1-yl)pyridine
(5k): Yellow oil. GC-MS: m/z (%) = 180 (59)[M]+,
179 (100), 123 (22); ¹H NMR (CDCl3,
200 MHz): δ = 1.51-1.63 (m,
6 H), 3.22-3.31 (m, 4 H), 6.11 (s, 1 H),
6.54 (dt, J
1 = 6.1 Hz, J
2 = 1.9 Hz,
1 H), 7.83 (d, J = 6.1 Hz,
1 H). ¹³C NMR (CDCl3,
50 MHz): δ = 24.2 (t), 25.0 (t), 91.3
(q, J
C-F = 42.0 Hz),
105.5 (s), 147.5 (q, J
C-F = 10.1 Hz),
158.8 (q, J
C-F = 11.7 Hz),
166.1 (d, J
C-F = 232.1 Hz).
N
-(2-Fluoropyridin-4-yl)pyridin-2-amine
(6a): Yellow solid; mp 143 ˚C;
GC-MS: m/z (%) = 188
(100), 189 (30)[M]+, 168 (8); ¹H
NMR (CDCl3, 200 MHz): δ = 6.80-6.90
(m, 2 H), 7.09 (d, J = 6.1 Hz,
1 H), 7.15 (s, 1 H), 7.32 (d, J = 1.8 Hz,
1 H), 7.64 (m, 1 H), 7.99 (d, J = 5.4 Hz,
1 H), 8.34 (d, J = 3.5 Hz,
1 H). ¹³C NMR (CDCl3,
50 MHz): δ = 95.9 (q, J
C-F = 43.2 Hz),
110.2 (q, J
C-F = 3.1 Hz),
11.7 (d), 117.5 (d), 138.1 (d), 147.7 (q, J
C-F = 17.3 Hz),
148.2 (d, J
C-F = 12.6 Hz),
151.8 (d), 153.5 (s), 165.2 (d, J
C-F = 233.4 Hz).
N
-(2-Fluoropyridin-4-yl)pyridin-3-amine
(6b): Colorless crystals; mp 152 ˚C; GC-MS: m/z (%) = 189
(100)[M]+, 188 (37), 168 (22); ¹H
NMR (CDCl3, 200 MHz): δ = 6.39
(d, J = 1.9 Hz,
1 H), 6.71 (d, J = 5.8 Hz,
1 H), 7.22-7.42 (m, 2 H), 7.61 (d, J = 8.8 Hz,
1 H), 7.91 (d, J = 5.9
Hz, 1 H), 8.40 (d, J = 4.1 Hz,
1 H), 8.51 (s, 1 H). ¹³C
NMR (CDCl3, 50 MHz): δ = 92.9
(q, J
C-F = 43.0 Hz),
108.3 (q, J
C-F = 3.1 Hz),
124.1 (d), 129.1 (d), 136.2 (s), 143.8 (d), 145.4 (d), 148.0 (q, J
C-F = 18.0 Hz),
154.6 (d, J
C-F = 12.0 Hz),
165.5 (d, J
C-F = 234.0 Hz).
N
-(2-Fluoropyridin-4-yl)-4-phenylthiazol-2-amine
(6c): Colorless crystals; mp 195 ˚C; GC-MS: m/z (%) = 271 (100)[M]+,
134 (49), 270 (39); ¹H NMR (CD3OD, 200 MHz): δ = 7.27
(s, 1 H), 7.39-7.49 (m, 4 H), 7.70 (d, J = 1.6 Hz,
1 H), 7.94 (d, J = 7.0 Hz,
2 H), 7.98 (d, J = 5.8 Hz,
1 H). ¹³C NMR (CD3OD,
50 MHz): δ = 95.9 (q, J
C-F = 49.4 Hz),
111.1 (q, J
C-F = 3.0 Hz),
127.0 (d), 128.9 (d), 143.8 (s), 148.0 (q, J
C-F = 19.4 Hz),
152.9 (d), 153.7 (d), 155.2 (q, J
C-F = 12.4 Hz),
165.2 (d, J
C-F = 239.3 Hz).
4-Iodo-2-(piperidin-1-yl)pyridine
(7): Yellow oil; GC-MS: m/z (%) = 288 (100)[M]+,
258 (63), 204 (34); ¹H NMR (CDCl3,
200 MHz): δ = 1.62 (s, 6 H),
3.50 (d, J = 5.5 Hz, 4 H),
6.89 (dd, J
1 = 5.1 Hz, J
2 = 1.2 Hz,
1 H), 6.99 (s, 1 H), 7.79 (d, J = 5.1 Hz,
1 H).¹³C NMR (CDCl3,
50 MHz): δ = 24.6 (t), 25.4 (t), 46.1
(t), 106.6 (s), 115.9 (d), 120.9 (d), 148.2 (d), 159.7 (s).